Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with DMRA: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
DMRA
Damora Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
DMRA
Damora Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
DMRA
No shared trading history for LLY and DMRA.
Shared co-movers: not yet measured (DMRA).
LLY, solid
DMRA, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,378.16
▼
−2.81%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
DMRA
Damora Therapeutics, Inc.
Change
21.51
▼
−6.21%
Regular session
Nov 5 '26
Mkt cap
$1.4B
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 5 '26
LLY
ELI Lilly & Co
vs
DMRA
Damora Therapeutics, Inc.
1,378.16
▼
−2.81%
Price
21.51
▼
−6.21%
$1.3T
Mkt cap
$1.4B
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,378.16
▼
−2.81%
vs
DMRA
21.51
▼
−6.21%
Regular session
Nov 5 '26